MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2003-08-07
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
44
Registration Number
NCT00066339
Locations
🇧🇪

Institut Jules Bordet, Brussels, Belgium

Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 3
Completed
Conditions
Lung Cancer
First Posted Date
2003-07-28
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
453
Registration Number
NCT00006352
Locations
🇳🇱

Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
First Posted Date
2003-07-09
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
86
Registration Number
NCT00064181
Locations
🇪🇬

National Cancer Institute - Cairo, Cairo, Egypt

🇭🇺

National Institute of Oncology, Budapest, Hungary

🇩🇪

Westpfalz-Klinikum GmbH, Kaiserslautern, Germany

and more 25 locations

Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
First Posted Date
2003-07-09
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
97
Registration Number
NCT00064207
Locations
🇫🇷

Clinique Tivoli, Bordeaux, France

🇫🇷

C.H.G. Beauvais, Beauvais, France

🇫🇷

Centre Hospitalier d'Abbeville, Abbeville, France

and more 56 locations

Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
First Posted Date
2003-06-17
Last Posted Date
2012-07-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
50
Registration Number
NCT00022594
Locations
🇧🇪

Universitair Ziekenhuis Antwerpen, Edegem, Belgium

🇫🇷

CHU Pitie-Salpetriere, Paris, France

🇫🇷

Centre de Lutte Contre le Cancer, Georges-Francois Leclerc, Dijon, France

and more 17 locations

Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Psychosocial Effects of Cancer and Its Treatment
Sexual Dysfunction and Infertility
Sexuality and Reproductive Issues
First Posted Date
2003-06-06
Last Posted Date
2013-10-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
385
Registration Number
NCT00062400
Locations
🇧🇪

Centre Hospitalier Etterbeek Ixelles, Brussels, Belgium

🇮🇹

Azienda Istituti Ospitalieri, Cremona, Italy

🇨🇱

Clinica Alemana, Santiago, Chile

and more 24 locations

High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Phase 1
Terminated
Conditions
Lung Cancer
First Posted Date
2003-06-06
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
14
Registration Number
NCT00062335
Locations
🇫🇷

Centre Antoine Lacassagne, Nice, France

🇧🇪

Institut Jules Bordet, Brussels, Belgium

🇧🇪

Akademisch Ziekenhuis Gent, Ghent, Belgium

and more 4 locations

Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer

Not Applicable
Terminated
Conditions
Chronic Myeloproliferative Disorders
Fever, Sweats, and Hot Flashes
Infection
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms
Neutropenia
Precancerous Condition
First Posted Date
2003-06-06
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
351
Registration Number
NCT00062231
Locations
🇸🇰

National Cancer Institute - Bratislava, Bratislava, Slovakia

🇹🇷

Ibn-i Sina Hospital, Ankara, Turkey

🇩🇪

Charite - Campus Charite Mitte, Berlin, Germany

and more 20 locations

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Phase 1
Completed
Conditions
Colorectal Cancer
Head and Neck Cancer
Metastatic Cancer
First Posted Date
2003-06-06
Last Posted Date
2012-01-20
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
27
Registration Number
NCT00062348
Locations
🇩🇪

Universitaetsklinikum Essen, Essen, Germany

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Phase 3
Completed
Conditions
Sarcoma
First Posted Date
2003-06-06
Last Posted Date
2014-10-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
455
Registration Number
NCT00061984
Locations
🇫🇷

Centre Leon Berard, Lyon, France

🇨🇭

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

🇨🇦

Doctor H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada

and more 38 locations
© Copyright 2025. All Rights Reserved by MedPath